Delpor Awarded $1.5 million NIH Grant for Exenatide Implant for the...

The NIDDK continues to fund Delpor’s efforts to utilize its NANOPOR™ technology in developing a matchstick-size subcutaneous implant device capable of delivering exenatide for 3-12 months through...(PRWeb June 14, 2017)Read the full story at http://www.prweb.com/releases/2017/06/prweb14423867.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news